Sigma-Aldrich Q4 Revenues Increase 4 Percent, Beat Analyst Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that revenues for its fourth quarter rose 4 percent year over year as the firm beat the consensus analyst estimate on the top and bottom lines.

Total revenues for the three months ended Dec. 31, 2013 reached $684 million, up from $655 million a year ago and above the average analyst estimate of $676 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.